France (FR)

On the inclusion of dissipation on top of mean-field approaches (2018) Dinh PM, Lacombe L, Reinhard PG, Suraud E, Vincendon M Journal article Minimal controllability time for finite-dimensional control systems under state constraints (2018) Loheac J, Trelat E, Zuazua E Journal article Characterisation and testing of CHEC-M-A camera prototype for the small-sized telescopes of the Cherenkov telescope array (2018) Zorn J, White R, Watson JJ, Armstrong TP, Balzer A, Barcelo M, Berge D, et al. Journal article, Original article Setup for meV-resolution inelastic X-ray scattering measurements and X-ray diffraction at the Matter in Extreme Conditions endstation at the Linac Coherent Light Source (2018) Mcbride EE, White TG, Descamps A, Fletcher LB, Appel K, Condamine FP, Curry CB, et al. Journal article In Situ Stability Studies of Platinum Nanoparticles Supported on Ruthenium-Titanium Mixed Oxide (RTO) for Fuel Cell Cathodes (2018) Hornberger E, Bergmann A, Schmies H, Kuehl S, Wang G, Drnec J, Sandbeck DJS, et al. Journal article Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility (2018) Machiela MJ, Gruenewald TGP, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, et al. Conference contribution Carboplatin/pegylated liposomal doxorubicin/bevacizumab (CD-BEV) vs. carboplatin/gemcitabine/bevacizumab (CG-BEV) in patients with recurrent ovarian cancer: A prospective randomized phase III ENGOT/GCIG-Intergroup study (AGO study group, AGO-Austria, ANZGOG, GINECO, SGCTG) (2018) Pfisterer J, Dean AP, Baumann K, Rau J, Harter P, Joly F, Sehouli J, et al. Conference contribution Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx) (2018) Yao JC, Strosberg J, Fazio N, Pavel ME, Ruszniewski P, Bergsland E, Li D, et al. Conference contribution Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib plus fulvestrant: Results from MONALEESA-3 (2018) Fasching P, Esteva FJ, Pivot X, Nusch A, Beck JT, Chan A, Pieris-Gunatilaka A, et al. Conference contribution Tuning the conductance of a molecular wire by the interplay of donor and acceptor units (2018) Skidin D, Erdmann T, Nikipar S, Eisenhut F, Krueger J, Guenther F, Gemming S, et al. Journal article